Bio-Thera Solutions, Ltd. (SHA:688177)

Bio-Thera Solutions Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-510.3	-394.53	-480.4	81.94
Depreciation & Amortization	87.86	85.24	83.84	72.94
Other Amortization	2.18	0.11	-	-
Loss (Gain) From Sale of Assets	0.01	-0.03	-0	-
Asset Writedown & Restructuring Costs	-2.95	-6.92	0.07	0.02
Loss (Gain) From Sale of Investments	-1.23	-3.87	-25.03	-27.6
Provision & Write-off of Bad Debts	0.23	0.19	-0.71	0.9
Other Operating Activities	20.86	11.78	0.63	0.69
Change in Accounts Receivable	44.85	-99.3	27.1	21.88
Change in Inventory	-21.87	-69.33	-71.8	-44.47
Change in Accounts Payable	299.37	41.14	53.48	129.99
Change in Other Net Operating Assets	25.35	-25.35	-	-
Operating Cash Flow	-55.65	-460.87	-412.82	236.27
Capital Expenditures	-126.85	-262.14	-258.82	-77.89
Sale of Property, Plant & Equipment	0	0	0.03	0
Investment in Securities	240	288	-28	340
Other Investing Activities	5.49	11.71	40.99	39.65
Investing Cash Flow	118.64	37.57	-245.8	301.76
Long-Term Debt Issued	378.93	441.85	3	30
Total Debt Issued	378.93	441.85	3	30
Long-Term Debt Repaid	-277.73	-34.97	-32.99	-2.91
Total Debt Repaid	-277.73	-34.97	-32.99	-2.91
Net Debt Issued (Repaid)	101.2	406.88	-29.99	27.09
Common Dividends Paid	-20.6	-9.32	-0.16	-0.55
Other Financing Activities	6.69	-2.4	-	-
Financing Cash Flow	87.28	395.16	-30.15	26.54
Foreign Exchange Rate Adjustments	0.61	0.57	0.77	-0.8
Net Cash Flow	150.88	-27.58	-688	563.77
Free Cash Flow	-182.5	-723.01	-671.64	158.38
Free Cash Flow Margin	-24.56%	-102.58%	-147.57%	18.93%
Free Cash Flow Per Share	-0.44	-1.74	-1.62	0.39
Cash Income Tax Paid	19.94	-23.92	-34.41	-24.37
Levered Free Cash Flow	-108.15	-591.18	-510.64	34.74
Unlevered Free Cash Flow	-95.31	-584.69	-510.6	35.23
Change in Working Capital	347.69	-152.84	8.78	107.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.